<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03146585</url>
  </required_header>
  <id_info>
    <org_study_id>AZVCR 9307_3</org_study_id>
    <nct_id>NCT03146585</nct_id>
  </id_info>
  <brief_title>Glycocalyx Damage in Critically Ill Patients</brief_title>
  <official_title>Alterations of Glycocalyx in Critical Illness and During Major Surgery and Approaches for Glycocalyx Protection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Hradec Kralove</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Hradec Kralove</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The hypothesis to be tested: GCX damage and its dynamics correlate to various patient related
      factors and to using organ-supporting measures. There is a correlation between length of
      organ support and GCX damage.

      The aim of the study: Evaluation of the relationship between GCX damage and duration of
      various organ supporting measures.

      Type of the study: Observational. Subjects: Adult patients admitted to ICU and requiring
      organ supporting therapy.

      Sample size: We plan enrollment of 75 patients on invasive ventilatory support in the
      duration of least 5 days, 50 patients on renal supporting therapy lasting at least 5 days and
      20 patients with target temperature management for neuroprotection.

      Intervention: none Data to be recorded and analysed: Demographics, type of patients (trauma,
      post surgical, medical, after cardiac arrest), severity score - Apache II, SOFA, fluid
      balance, presence of delirium, clinical outcome, sublingual microcirculation by SDF imaging
      at time points: before or at the start of organ support, after 24 hours (day 1), day 3, 5, 7
      and/or at discharge or before death, microcirculatory data, and Perfused Boundary Region.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 1, 2015</start_date>
  <completion_date type="Actual">June 30, 2018</completion_date>
  <primary_completion_date type="Actual">December 31, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Perfused Boundary Region (PBR) in One Week</measure>
    <time_frame>One week on ICU</time_frame>
    <description>PBR is an indirect measure of assessment of the endothelial glycocalyx thickness in sublingual microcirculation.</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">40</enrollment>
  <condition>Critical Illness</condition>
  <arm_group>
    <arm_group_label>Patients on artificial ventilation</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients on renal replacement therapy</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with targeted temperature management</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PBR assessment</intervention_name>
    <description>Sublingual microcirculation will be investigated by specialized handheld videomicroscopy device for PBR index.</description>
    <arm_group_label>Patients on artificial ventilation</arm_group_label>
    <arm_group_label>Patients on renal replacement therapy</arm_group_label>
    <arm_group_label>Patients with targeted temperature management</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients admitted to ICU meeting inclusion criteria.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adult patients admitted to ICU

          -  artifitial ventilation

          -  renal replacement therapy

          -  targeted temperatura management

        Exclusion Criteria:

          -  pregnant women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vladimir Cerny, MD, PhD, FCCM</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Hradec Kralove</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Hradec Kralove</name>
      <address>
        <city>Hradec Králové</city>
        <state>Třebeš</state>
        <zip>50005</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Czechia</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>May 7, 2017</study_first_submitted>
  <study_first_submitted_qc>May 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 10, 2017</study_first_posted>
  <results_first_submitted>March 25, 2019</results_first_submitted>
  <results_first_submitted_qc>March 27, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">March 30, 2020</results_first_posted>
  <last_update_submitted>March 27, 2020</last_update_submitted>
  <last_update_submitted_qc>March 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Hradec Kralove</investigator_affiliation>
    <investigator_full_name>Vladimir Cerny</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>Glycocalyx</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>November 7, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/85/NCT03146585/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Adult patients admitted to our ICU with any kind of organ support.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Patients on Artificial Ventilation</title>
          <description>PBR assessment: Sublingual microcirculation will be investigated by specialized handheld videomicroscopy device for PBR index.</description>
        </group>
        <group group_id="P2">
          <title>Patients on Renal Replacement Therapy</title>
          <description>PBR assessment: Sublingual microcirculation will be investigated by specialized handheld videomicroscopy device for PBR index.</description>
        </group>
        <group group_id="P3">
          <title>Patients With Targeted Temperature Management</title>
          <description>PBR assessment: Sublingual microcirculation will be investigated by specialized handheld videomicroscopy device for PBR index.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
                <participants group_id="P2" count="10"/>
                <participants group_id="P3" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
                <participants group_id="P2" count="10"/>
                <participants group_id="P3" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Patients on Artificial Ventilation</title>
          <description>PBR assessment: Sublingual microcirculation will be investigated by specialized handheld videomicroscopy device for PBR index.</description>
        </group>
        <group group_id="B2">
          <title>Patients on Renal Replacement Therapy</title>
          <description>PBR assessment: Sublingual microcirculation will be investigated by specialized handheld videomicroscopy device for PBR index.</description>
        </group>
        <group group_id="B3">
          <title>Patients With Targeted Temperature Management</title>
          <description>PBR assessment: Sublingual microcirculation will be investigated by specialized handheld videomicroscopy device for PBR index.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="25"/>
            <count group_id="B2" value="10"/>
            <count group_id="B3" value="5"/>
            <count group_id="B4" value="40"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="25"/>
                    <count group_id="B2" value="10"/>
                    <count group_id="B3" value="5"/>
                    <count group_id="B4" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="40"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="25"/>
                    <count group_id="B2" value="10"/>
                    <count group_id="B3" value="5"/>
                    <count group_id="B4" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45" spread="5"/>
                    <measurement group_id="B2" value="50" spread="6"/>
                    <measurement group_id="B3" value="62" spread="3"/>
                    <measurement group_id="B4" value="60" spread="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="25"/>
                    <count group_id="B2" value="10"/>
                    <count group_id="B3" value="5"/>
                    <count group_id="B4" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                    <count group_id="B4" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Czechia</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="25"/>
                    <count group_id="B2" value="10"/>
                    <count group_id="B3" value="5"/>
                    <count group_id="B4" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>PBR value</title>
          <description>The Perfused Boundary Region (PBR) is an indirect assessment of the thickness of the endothelial glycocalyx in sublingual microcirculation.</description>
          <units>micrometer</units>
          <param>Mean</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="25"/>
                    <count group_id="B2" value="10"/>
                    <count group_id="B3" value="5"/>
                    <count group_id="B4" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2.02" lower_limit="1.92" upper_limit="2.20"/>
                    <measurement group_id="B2" value="2.13" lower_limit="2.02" upper_limit="2.28"/>
                    <measurement group_id="B3" value="2.07" lower_limit="1.92" upper_limit="2.32"/>
                    <measurement group_id="B4" value="2.10" lower_limit="2.00" upper_limit="2.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Perfused Boundary Region (PBR) in One Week</title>
        <description>PBR is an indirect measure of assessment of the endothelial glycocalyx thickness in sublingual microcirculation.</description>
        <time_frame>One week on ICU</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Patients on Artificial Ventilation</title>
            <description>PBR assessment: Sublingual microcirculation will be investigated by specialized handheld videomicroscopy device for PBR index.</description>
          </group>
          <group group_id="O2">
            <title>Patients on Renal Replacement Therapy</title>
            <description>PBR assessment: Sublingual microcirculation will be investigated by specialized handheld videomicroscopy device for PBR index.</description>
          </group>
          <group group_id="O3">
            <title>Patients With Targeted Temperature Management</title>
            <description>PBR assessment: Sublingual microcirculation will be investigated by specialized handheld videomicroscopy device for PBR index.</description>
          </group>
        </group_list>
        <measure>
          <title>Perfused Boundary Region (PBR) in One Week</title>
          <description>PBR is an indirect measure of assessment of the endothelial glycocalyx thickness in sublingual microcirculation.</description>
          <units>micrometer</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.95" lower_limit="1.77" upper_limit="2.12"/>
                    <measurement group_id="O2" value="1.97" lower_limit="1.75" upper_limit="2.12"/>
                    <measurement group_id="O3" value="2.02" lower_limit="1.71" upper_limit="2.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <desc>Adverse events were not collected since the study is observational. If the patient died it was due to the natural course of the disease.</desc>
      <group_list>
        <group group_id="E1">
          <title>Patients on Artificial Ventilation</title>
          <description>PBR assessment: Sublingual microcirculation will be investigated by specialized handheld videomicroscopy device for PBR index.</description>
        </group>
        <group group_id="E2">
          <title>Patients on Renal Replacement Therapy</title>
          <description>PBR assessment: Sublingual microcirculation will be investigated by specialized handheld videomicroscopy device for PBR index.</description>
        </group>
        <group group_id="E3">
          <title>Patients With Targeted Temperature Management</title>
          <description>PBR assessment: Sublingual microcirculation will be investigated by specialized handheld videomicroscopy device for PBR index.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. David Astapenko</name_or_title>
      <organization>University Hospital Hradec Kralove</organization>
      <phone>+420608177374</phone>
      <email>astapenko.d@seznam.cz</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

